A phase I/II, open label trial of Lewis Y specific monoclonal antibody IGN311 to evaluate safety and efficacy in patients with malignant effusion This is an ASCO Meeting Abstract from the 2006 ASCO ...
Leading Malignant Pleural Effusion companies in the market include - RS Oncology, Genelux Corporation, Candel Therapeutics, and others. The Malignant Pleural Effusion Market is projected to experience ...
Malignant pleural mesothelioma (MPM) is a primary and locally aggressive tumor of the pleura. A well defined causal relationship with asbestos exposure, and an overwhelming media interest in the use ...
Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Pleural Effusion Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...
DelveInsight's“ Malignant Pleural Effusion Pipeline Insight” report provides comprehensive global coverage of pipeline therapies for Malignant Pleural Effusion across various stages of clinical ...
Lung cancer patients are particularly susceptible to malignant pleural effusion, when fluid collects in the space between the lungs and the chest wall. Researchers at the Helmholtz Zentrum München, in ...
Hepatic hydrothorax is a respiratory condition that affects people with cirrhosis and other serious liver issues. It occurs when fluid builds up in the pleural space. Hepatic hydrothorax is a ...
Predictors of Viridans Streptococcal Shock Syndrome in Bacteremic Children With Cancer and Stem-Cell Transplant Recipients One hundred sixty patients with rapidly recurrent malignant pleural effusion ...
The 50-ml. syringe is filled with saline solution. This is rapidly injected into the 10-ml. vial containing 2 or 3 ml. of Au 198. The total volume of saline solution and isotope goes directly into the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results